Drug intelligence / Profile preview

Iris nertschinskia ethanol extract

Development stage
Preclinical
Lead developer
Asan Medical Center
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Parenteral
01

Overview

Iris nertschinskia ethanol extract is a botanical extract derived from the ornamental plant *Iris nertschinskia* (also known as *Xiphion orientale*), which has historically been used in traditional East Asian medicine to treat skin diseases and inflammation. Preclinical research has demonstrated that this extract possesses anti-tumor activity, specifically inducing p53-dependent apoptosis in human breast cancer cell lines (such as MCF7) by promoting p53 phosphorylation, inducing Bax protein expression, and triggering caspase-7 cleavage. Additionally, its cytotoxic effects are modulated by AKT signaling, with cell death induction varying based on the levels of phosphorylated AKT1 and AKT2. A South Korean patent (KR101104269B1) covers a pharmaceutical composition of this extract for cancer prevention and treatment, though it remains in the academic and preclinical stages of research with no commercial developers or clinical trials.

Other names
Iris nertschinskia ethanolic extractIris nertschinskia extractXiphion orientale ethanol extractXiphion orientale extract
02

Targets

BAX (Apoptosis regulator BAX)CASP7 (Caspase-7)AKT2 (Rac-beta serine/threonine-protein kinase)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)

Beyond the preview

Go deeper on Iris nertschinskia ethanol extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iris nertschinskia ethanol extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call